Clinical Trials Directory

Trials / Completed

CompletedNCT05242367

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for PTSD

A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Treatment of Post- Traumatic Stress Disorder (PTSD)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
383 (actual)
Sponsor
Neurovalens Ltd. · Industry
Sex
All
Age
22 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Trial title: A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Treatment of PTSD The aim of this study: To better evaluate the efficacy of non-invasive electrical vestibular nerve stimulation (VeNS) as a method of treating PTSD, as compared to a sham control. Allocation: Randomized to either active device or control device usage. Endpoint classification: Efficacy Study Intervention Model: Parallel Assignment in 1:1 active to control allocation Sample size: The aim is to recruit a total of up to 400 participants. The study will last 12 weeks in total for each subject.

Conditions

Interventions

TypeNameDescription
DEVICEModius Spero active deviceBattery powered non-invasive neurostimulation device
DEVICESham devicePlacebo comparator sham device (no active stimulation)

Timeline

Start date
2023-02-13
Primary completion
2024-12-02
Completion
2024-12-02
First posted
2022-02-16
Last updated
2025-06-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05242367. Inclusion in this directory is not an endorsement.